Eculizumab (Soliris), a first-in-class complement inhibitor, is now approved for AQP4 antibody-positive neuromyelitis optica spectrum disorder (NMOSD) following an expedited 6-month priority review. Source: AAO
In this retrospective case series, investigators report the characteristics of and surgical approach to patients with restrictive diplopia following pterygium excision. Source: AAO
Due to a lack of sterility assurance, the FDA has issued a warning not to use any sterile drug products—including bevacizumab (Avastin)—produced by Pacifico National Inc, doing business as AmEx Pharmacy in Melbourne, Florida. Source: AAO
Investigators evaluated a water-free cyclosporine formulation (CyclASol) for moderate to severe dry eye disease. Source: AAO
Investigators report outcomes of wavefront-guided photorefractive keratectomy (WG-PRK) for high astigmatism after keratoplasty. Source: AAO
This week, Orion’s visual prosthesis gives the Argus II a run for its money, a Brazilian startup presents an affordable and portable ophthalmoscope and an international team eradicates Botswana’s backlog of 6,000 cataract blindness cases. Source: AAO
This study compared the incidence of intraoperative floppy-iris syndrome (IFIS) in male and female patients undergoing cataract surgery. Source: AAO
AbbVie has agreed to acquire Allergan for $63 billion, unlocking key opportunities for growth on both sides of the deal. Source: AAO
Investigators explored the incidence of and risk factors for developing persistent low-pressure syndrome after lumbar puncture (LP) in patients with idiopathic intracranial hypertension (IIH). Source: AAO
This prospective study investigated the efficacy and safety of pembrolizumab as a first-line therapy for metastatic uveal melanoma. Source: AAO